147 related articles for article (PubMed ID: 24148991)
1. Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.
Jeankumar VU; Renuka J; Santosh P; Soni V; Sridevi JP; Suryadevara P; Yogeeswari P; Sriram D
Eur J Med Chem; 2013; 70():143-53. PubMed ID: 24148991
[TBL] [Abstract][Full Text] [Related]
2. Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.
Kale MG; Raichurkar A; P SH; Waterson D; McKinney D; Manjunatha MR; Kranthi U; Koushik K; Jena Lk; Shinde V; Rudrapatna S; Barde S; Humnabadkar V; Madhavapeddi P; Basavarajappa H; Ghosh A; Ramya VK; Guptha S; Sharma S; Vachaspati P; Kumar KN; Giridhar J; Reddy J; Panduga V; Ganguly S; Ahuja V; Gaonkar S; Kumar CN; Ogg D; Tucker JA; Boriack-Sjodin PA; de Sousa SM; Sambandamurthy VK; Ghorpade SR
J Med Chem; 2013 Nov; 56(21):8834-48. PubMed ID: 24088190
[TBL] [Abstract][Full Text] [Related]
3. Aminopyrazinamides: novel and specific GyrB inhibitors that kill replicating and nonreplicating Mycobacterium tuberculosis.
Shirude PS; Madhavapeddi P; Tucker JA; Murugan K; Patil V; Basavarajappa H; Raichurkar AV; Humnabadkar V; Hussein S; Sharma S; Ramya VK; Narayan CB; Balganesh TS; Sambandamurthy VK
ACS Chem Biol; 2013 Mar; 8(3):519-23. PubMed ID: 23268609
[TBL] [Abstract][Full Text] [Related]
4. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
Sriram D; Aubry A; Yogeeswari P; Fisher LM
Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
[TBL] [Abstract][Full Text] [Related]
5. 2-(2-Hydrazinyl)thiazole derivatives: design, synthesis and in vitro antimycobacterial studies.
Makam P; Kankanala R; Prakash A; Kannan T
Eur J Med Chem; 2013 Nov; 69():564-76. PubMed ID: 24095750
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel gyrase B inhibitors as potential anti-TB drugs: homology modelling, hybrid virtual screening and molecular dynamics simulations.
Maharaj Y; Soliman ME
Chem Biol Drug Des; 2013 Aug; 82(2):205-15. PubMed ID: 23614896
[TBL] [Abstract][Full Text] [Related]
7. Novel 2-(2-benzylidenehydrazinyl)benzo[d]thiazole as potential antitubercular agents.
Bairwa VK; Telvekar VN
Comb Chem High Throughput Screen; 2013 Mar; 16(3):244-7. PubMed ID: 23176058
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
[TBL] [Abstract][Full Text] [Related]
10. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem Lett; 2008 Feb; 18(3):1229-36. PubMed ID: 18068979
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 3-heteroarylthioquinoline derivatives and their in vitro antituberculosis and cytotoxicity studies.
Chitra S; Paul N; Muthusubramanian S; Manisankar P; Yogeeswari P; Sriram D
Eur J Med Chem; 2011 Oct; 46(10):4897-903. PubMed ID: 21855182
[TBL] [Abstract][Full Text] [Related]
12. Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.
Ronkin SM; Badia M; Bellon S; Grillot AL; Gross CH; Grossman TH; Mani N; Parsons JD; Stamos D; Trudeau M; Wei Y; Charifson PS
Bioorg Med Chem Lett; 2010 May; 20(9):2828-31. PubMed ID: 20356737
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antituberculosis activity of new thiazolylhydrazone derivatives.
Turan-Zitouni G; Ozdemir A; Kaplancikli ZA; Benkli K; Chevallet P; Akalin G
Eur J Med Chem; 2008 May; 43(5):981-5. PubMed ID: 17719146
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of substituted 4-arylthiazol-2-amino derivatives as potent growth inhibitors of replicating Mycobacterium tuberculosis H₃₇Rv.
Roy KK; Singh S; Sharma SK; Srivastava R; Chaturvedi V; Saxena AK
Bioorg Med Chem Lett; 2011 Sep; 21(18):5589-93. PubMed ID: 21783364
[TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
Sriram D; Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V
J Med Chem; 2007 Nov; 50(24):6232-9. PubMed ID: 17960928
[TBL] [Abstract][Full Text] [Related]
17. Bioisosteric Design Identifies Inhibitors of
Kamsri B; Pakamwong B; Thongdee P; Phusi N; Kamsri P; Punkvang A; Ketrat S; Saparpakorn P; Hannongbua S; Sangswan J; Suttisintong K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Leanpolchareanchai J; Goudar KE; Spencer J; Mulholland AJ; Pungpo P
J Chem Inf Model; 2023 May; 63(9):2707-2718. PubMed ID: 37074047
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.
Chopra S; Matsuyama K; Tran T; Malerich JP; Wan B; Franzblau SG; Lun S; Guo H; Maiga MC; Bishai WR; Madrid PB
J Antimicrob Chemother; 2012 Feb; 67(2):415-21. PubMed ID: 22052686
[TBL] [Abstract][Full Text] [Related]
19. Discovery of antimycobacterial spiro-piperidin-4-ones: an atom economic, stereoselective synthesis, and biological intervention.
Kumar RR; Perumal S; Senthilkumar P; Yogeeswari P; Sriram D
J Med Chem; 2008 Sep; 51(18):5731-5. PubMed ID: 18714980
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
